p27KIP1-expression in human renal cell cancers: Implications for clinical outcome

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 217-221

  Anastasiadis, Aristotelis G ^a,b   Calvo Sanchez, David ^a   Franke, Knut H ^a   Ebert, Thomas ^a   Heydthausen, Manfred ^a   Schulz, Wolfgang A ^a   Burchardt, Martin ^a   Gerharz, Claus Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Herbert Irving Pavilion ^*  (United States)

Author keywords

Cell cycle regulators; p27Kip1 protein; Renal cell cancer

Indexed keywords

PROTEIN P27; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; BIOSYNTHESIS; EPITHELIUM CELL; GLOMERULUS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037231594     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487-96, 1994.
2. Koff A, Ohtsuki M, Polyak K, Roberts JM and Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260: 526-39, 1993.
3. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66, 1994.
4. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994.
5. Slingerland JM, Hengst L, Pan CH et al.: A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 14: 3683-94, 1994.
6. Firpo EJ, Koff A, Solomon MJ and Roberts JM: Inactivation of Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 14: 4889-4901, 1994.
7. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-73, 1994.
8. Toyoshima H and Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.
9. Kranenburg O, Scharnhorst V, Van der Eb AJ and Zantema A: Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol 131: 227-34, 1995.
10. Liu M, Lee MH, Cohen M, Bommakanti M and Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-53, 1996.
11. Kip1. J Clin Invest 97: 1983-88, 1996.
12. Tsihlias J, Kapusta L and Slingerland J: The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 50: 401-23, 1999.
13. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, DeKernion J, Loda M and Reiter RE: Low p27 expression predicts poor diseasefree survival in patients with prostate cancer. J Urol 159: 941-45, 1998.
14. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Medicine 3: 222-25, 1997.
15. Kip1 protein: prognostic implications in primary breast cancer. Nat Medicine 3: 227-30, 1997.
16. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Medicine 3: 231-34, 1997.
17. Delahunt B: Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 15: 68-76, 1998.
18. Thoenes W, Stoerkel S and Rummelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181: 125-43, 1986.
19. Stoerkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B and Lezkowski K: Classification of renal cell carcinoma. Cancer 80: 987-89, 1997.
20. UICC: TNM Classification of Malignant Tumours. 5th ed. (Sobin LH, Wittekind Ch., eds.). John Wiley & Sons, New York.
21. Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter. BJU Int 86: 14-9, 2000.
22. Peto R, Pyke MC and Armatage NE: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 53-58, 1977.
23. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K and Akiyoshi T: p27 expression and gastric carcinoma. Nat Med 3: 593, 1997.
24. Esposito V, Baldi A, De Luca A, Grogor AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A: Prognostic role of the cyclin dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-85, 1997.
25. Masuda M, Takano Y, Iki M, Makiyama K, Ikeda I, Noguchi S, Hasegawa Y and Hosaka M: Cyclin-dependent kinase inhibitor p27(Kip1) expression in transitional cell carcinoma of renal pelvis and ureter. Cancer Lett 150: 183-9, 2000.
26. Kip1, in developing and mature human kidney. Kidney Int 53: 892-96, 1998.
27. Hedberg Y, Davoodi E, Roos G, Ljungberg B and Landberg G: Cyclin-D1 expression in human renal cell carcinoma. Int J Cancer 84: 268-72, 1999.
28. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjanen K and Kosma VM: Expression of cyclins A and D and p21 (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 80: 2001-07, 1999.
29. Haitel A, Wiener HG, Neudert B, Marberger M and Susani M: Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 58: 477-81, 2001.
30. Migita T, Oda Y, Naito S and Tsuneyoshi M: Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 94: 973-9, 2002.